Key result
Calcific aortic valve disease was associated with a significant 2.1-fold downregulation of heat shock protein 90 (HSP90) compared to non-calcified control valves.
Why the study?
There is no effective pharmacological treatment for calcific aortic valve disease and many of the underlying molecular mechanisms remain unknown.
Case-Control (n=50)
No
This proteomic study identifies novel molecular changes in calcific aortic valve disease, notably the downregulation of the pro-inflammatory cytosolic protein HSP90, which may offer new mechanistic insights.
HSP90 downregulation in calcific aortic valve disease is hypothesis-generating; should not yet change practice.
BACKGROUND: Calcific aortic valve disease (CAVD) is an atheroinflammatory process; finally it leads to progressive calcification of the valve. There is no effective pharmacological treatment for CAVD and many of the underlying molecular mechanisms remain unknown. We conducted a proteomic study to reveal novel factors associated with CAVD. METHODS: We compared aortic valves from patients undergoing valvular replacement surgery due to non-calcified aortic insufficiency (control group, n = 5) to a stenotic group (n = 7) using two-dimensional difference gel electrophoresis (2D-DIGE). Protein spots were identified with mass spectrometry. Western blot and immunohistochemistry were used to validate the results in a separate patient cohort and Ingenuity Pathway Analysis (IPA) was exploited to predict the regulatory network of CAVD. RESULTS: We detected an upregulation of complement 9 (C9), serum amyloid P-component (APCS) and transgelin as well as downregulation of heat shock protein (HSP90), protein disulfide isomerase A3 (PDIA3), annexin A2 (ANXA2) and galectin-1 in patients with aortic valve stenosis. The decreased protein expression of HSP90 was confirmed with Western blot. CONCLUSIONS: We describe here a novel data set of proteomic changes associated with CAVD, including downregulation of the pro-inflammatory cytosolic protein, HSP90.
No takes yet. Share an insight, caveat, or question.
Weisell et al. (2019) conducted a case-control in Calcific aortic valve disease (n=50). Calcific aortic valve disease vs. Normal, non-calcified aortic valves was evaluated on Differential protein expression (HSP90) (2.1-fold downregulation, p=0.022). Calcific aortic valve disease was associated with a significant 2.1-fold downregulation of heat shock protein 90 (HSP90) compared to non-calcified control valves.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: